LCI  valuation analysis

Basics
Name: Lannett Company, Inc
Description: Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 03, 2021
Market cap: $196.34M (1397th)
Sales(TTM): $542.69M (1175th)
Earnings(TTM): -$228.41M (1236th)

Value
FFER: 0.24 (why)
Actual price: $4.97
FFEThis is Lannett Company, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $23.78
Quantile: LCI is very cheap given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Lannett Company, Inc's operating income decreased from $68.96M to -$223.24M in the last year.
Earnings / MarketCap
Lannett Company, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Lannett Company, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Lannett Company, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Lannett Company, Inc
"Drug Manufacturers-Specialty & Generic" industry